Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Frederick M. Hudson
12 Mar 2026
Director
Sell
5,369
$50.61
$271.73K
William Todd Horich
10 Mar 2026
SVP, Commercial Operations
Sell
4,439
$55.00
$244.15K
William Todd Horich
9 Mar 2026
SVP, Commercial Operations
Sell
4,438
$54.00
$239.65K
Frank Mottola
9 Mar 2026
SVP, Chief Tech. Ops. Officer
Sell
1,623
$53.65
$87.07K
Georges Gemayel
5 Mar 2026
Director
Sell
10,000
$53.71
$537.10K

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 2,909,472
History held since 7 May 2012